Broad-spectrum antiviral inhibitors targeting pandemic potential RNA viruses

RNA viruses continue to remain a clear and present threat for potential pandemics due to their rapid evolution. To mitigate their impact, we urgently require antiviral agents that can inhibit multiple families of disease-causing viruses, such as arthropod-borne and respiratory pathogens. Potentiating host antiviral pathways can prevent or limit viral infections before escalating into a major outbreak. Therefore, it is critical to identify broad-spectrum antiviral agents. We have tested a small library of innate immune agonists targeting pathogen recognition receptors, including TLRs, STING, NOD, Dectin and cytosolic DNA or RNA sensors. We observed that TLR3, STING, TLR8 and Dectin-1 ligands inhibited arboviruses, Chikungunya virus (CHIKV), West Nile virus (WNV) and Zika virus, to varying degrees. Cyclic dinucleotide (CDN) STING agonists, such as cAIMP, diABZI, and 2’,3’-cGAMP, and Dectin-1 agonist scleroglucan, demonstrated the most potent, broad-spectrum antiviral function. Comparative transcriptome analysis revealed that CHIKV-infected cells had larger number of differentially expressed genes than of WNV and ZIKV. Furthermore, gene expression analysis showed that cAIMP treatment rescued cells from CHIKV-induced dysregulation of cell repair, immune, and metabolic pathways. In addition, cAIMP provided protection against CHIKV in a CHIKV-arthritis mouse model. Cardioprotective effects of synthetic STING ligands against CHIKV, WNV, SARS-CoV-2 and enterovirus D68 (EV-D68) infections were demonstrated using human cardiomyocytes. Interestingly, the direct-acting antiviral drug remdesivir, a nucleoside analogue, was not effective against CHIKV and WNV, but exhibited potent antiviral effects against SARS-CoV-2, RSV (respiratory syncytial virus), and EV-D68. Our study identifies broad-spectrum antivirals effective against multiple families of pandemic potential RNA viruses, which can be rapidly deployed to prevent or mitigate future pandemics.

[1]  P. Shah,et al.  Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response , 2022, PLoS biology.

[2]  W. Nguitragool,et al.  Spread of a Novel Indian Ocean Lineage Carrying E1-K211E/E2-V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa , 2022, Microorganisms.

[3]  R. Siegel,et al.  TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis. , 2021, Cell reports.

[4]  Simon Van Herck,et al.  Delivery of STING agonists for adjuvanting subunit vaccines. , 2021, Advanced drug delivery reviews.

[5]  D. van Riel,et al.  The pathogenesis and virulence of enterovirus-D68 infection , 2021, Virulence.

[6]  P. J. Kranzusch,et al.  cGAS-like receptors sense RNA and control 3′2′-cGAMP signalling in Drosophila , 2021, Nature.

[7]  Emily M. Lee,et al.  Pharmacological activation of STING blocks SARS-CoV-2 infection , 2021, Science Immunology.

[8]  R. Bartenschlager,et al.  Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication , 2021, Cell Reports.

[9]  Y. Poovorawan,et al.  Large-scale outbreak of Chikungunya virus infection in Thailand, 2018–2019 , 2021, PloS one.

[10]  D. Tegunov,et al.  Mechanism of SARS-CoV-2 polymerase stalling by remdesivir , 2021, Nature communications.

[11]  E. Fikrig,et al.  A critical role for STING signaling in limiting pathogenesis of Chikungunya virus. , 2020, The Journal of infectious diseases.

[12]  Xue-min Gao,et al.  A highly heterogeneous mutational pattern in POEMS syndrome , 2020, Leukemia.

[13]  S. Aguirre,et al.  Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS , 2020, PLoS pathogens.

[14]  A. C. C. da Costa,et al.  Association Between Antenatal Exposure to Zika Virus and Anatomical and Neurodevelopmental Abnormalities in Children , 2020, JAMA network open.

[15]  G. P. D. da Silva,et al.  Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World , 2020, Frontiers in Microbiology.

[16]  A. Failloux,et al.  Detection of arboviruses in mosquitoes: Evidence of circulation of chikungunya virus in Iran , 2020, PLoS neglected tropical diseases.

[17]  K. Fitzgerald,et al.  DNA sensing by the cGAS–STING pathway in health and disease , 2019, Nature Reviews Genetics.

[18]  P. Shil,et al.  Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6/36 cells & Aedes aegypti mosquitoes to three strains of chikungunya virus , 2019, The Indian journal of medical research.

[19]  J. García-Cordero,et al.  Competitive suppression of dengue virus replication occurs in chikungunya and dengue co-infected Mexican infants , 2018, Parasites & Vectors.

[20]  Z. Jing,et al.  The cGas–Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus , 2018, Front. Immunol..

[21]  Toshiyuki Shimizu,et al.  Mechanisms controlling nucleic acid-sensing Toll-like receptors , 2018, International immunology.

[22]  S. Chattopadhyay,et al.  Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity , 2018, Scientific Reports.

[23]  M. Heise,et al.  Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway , 2017, Journal of Virology.

[24]  D. Gubler,et al.  History and Emergence of Zika Virus , 2017, The Journal of infectious diseases.

[25]  Siqing Liu,et al.  Extensive evolution analysis of the global chikungunya virus strains revealed the origination of CHIKV epidemics in Pakistan in 2016 , 2017, Virologica Sinica.

[26]  G. Pijlman,et al.  Mosquito co-infection with Zika and chikungunya virus allows simultaneous transmission without affecting vector competence of Aedes aegypti , 2017, PLoS neglected tropical diseases.

[27]  A. Act,et al.  Zika Virus Infection in Pregnant Women in Rio de Janeiro - Preliminary Report. , 2016 .

[28]  Jessica L Smith,et al.  Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses , 2015, PLoS pathogens.

[29]  S. Paz.  Climate change impacts on West Nile virus transmission in a global context , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[30]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[31]  Zhijian J. Chen,et al.  The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. , 2014, Molecular cell.

[32]  A. Nisalak,et al.  Kinetics of Chikungunya Infections during an Outbreak in Southern Thailand, 2008–2009 , 2014, The American journal of tropical medicine and hygiene.

[33]  J. Hiscott,et al.  Inhibition of Dengue and Chikungunya Virus Infections by RIG-I-Mediated Type I Interferon-Independent Stimulation of the Innate Antiviral Response , 2014, Journal of Virology.

[34]  M. Diamond,et al.  Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity , 2013, Nature.

[35]  A. Iwasaki,et al.  ELF4 is critical for induction of type I interferon and the host antiviral response , 2013, Nature Immunology.

[36]  Zhijian J. Chen,et al.  Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects , 2013, Science.

[37]  Nan Yan,et al.  Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses , 2013, Science.

[38]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[39]  A. Basu,et al.  STING Mediates Neuronal Innate Immune Response Following Japanese Encephalitis Virus Infection , 2012, Scientific Reports.

[40]  Xiaoping Zhou,et al.  Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity , 2011, Cell.

[41]  Paolo Barbier,et al.  Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection , 2010, BMC infectious diseases.

[42]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[43]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[44]  Osamu Takeuchi,et al.  Innate immunity to virus infection , 2009, Immunological reviews.

[45]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[46]  M. Yoneyama,et al.  Structural mechanism of RNA recognition by the RIG-I-like receptors. , 2008, Immunity.

[47]  D. Davies,et al.  Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.

[48]  P. Desprès,et al.  Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection , 2007, PloS one.

[49]  J. Manson,et al.  Prospective Study of , 2007 .

[50]  R. DeBiasi,et al.  West Nile virus meningoencephalitis , 2006, Nature Clinical Practice Neurology.

[51]  Gordon D. Brown.  Dectin-1: a signalling non-TLR pattern-recognition receptor , 2006, Nature Reviews Immunology.

[52]  A. R.,et al.  Review of literature , 1969, American Potato Journal.

[53]  I Kilpeläinen,et al.  Membrane Binding Mechanism of an RNA Virus-capping Enzyme* , 2000, The Journal of Biological Chemistry.

[54]  P. Auvinen,et al.  Semliki Forest virus mRNA capping enzyme requires association with anionic membrane phospholipids for activity , 1999, The EMBO journal.

[55]  R. Darveau.  Infection, inflammation, and cancer , 1999, Nature Biotechnology.

[56]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[57]  J. H. Strauss,et al.  Sindbis virus RNA polymerase is degraded by the N-end rule pathway. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Robert C. Wolpert,et al.  A Review of the , 1985 .